feed,title,long_url,short_url
Benzinga,GeoVax Labs Retains CATO SMS To Manage Its Mis-Stage COVID-19 Vaccine Trials,https://benzinga.com/general/biotech/22/03/26125397/geovax-labs-retains-cato-sms-to-manage-its-mis-stage-covid-19-vaccine-trials,https://bit.ly/3Kz2Gzo
Benzinga,"Solid Biosciences Posts Two-Year Efficacy, Safety Data From Duchenne Gene Therapy Trial",https://benzinga.com/general/biotech/22/03/26124742/solid-biosciences-posts-two-year-efficacy-safety-data-from-duchenne-gene-therapy-trial,https://bit.ly/3CGAXtH
